Published in Lab Business Week, January 30th, 2005
Net sales for the second quarter of fiscal 2005 were $14.4 million, up 22%, compared with net sales of $11.9 million for the second quarter of fiscal year 2004. This increase was primarily due to strong growth from the company's newest products, along with continued market share gains across the entire product portfolio.
VenaCure, AngioDynamics' precision laser system for the treatment of severe varicose veins, continues to post robust sales growth. The company also had strong market penetration with its Morpheus CT PICC (peripherally inserted...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week